Baidu Encyclopedia shows that Yantai Wanrun Fine Chemical Co., Ltd. has always adhered to the international market-oriented business strategy, continuously expanded the production scale of monomer liquid crystals and liquid crystal intermediates, and gradually increased investment in research and development of pharmaceutical intermediates, optimized the company's product structure, increased operating income and improved profitability. Registered capital: 93,065,438+03.02150,000 yuan (RMB), business status: opening, company type: joint stock limited company (listed), sales: 654,380.2 million USD (2,065,438+065,438). Yantai Wanrun Fine Chemical Co., Ltd. has a perfect talent training scheme and a sound incentive mechanism. New employees will receive three-level training from the time they enter the company. This is an open learning garden. During working in the company, employees get different training and learning opportunities in technology, English and management. So Yantai Wanrun is a good unit.

Yantai Wanrun Fine Chemical Co., Ltd. is transforming cGMP (American Good Manufacturing Practice) standard to improve production management level, broaden product production scope and expand economic scale. The new API workshop (according to cGMP standard) has a total investment of more than 20 million yuan, and the designed annual production capacity is 65.438 million tons of APIs. It is about to start production, and all products are exported to Japan, with annual sales of 80 million and annual profit of 65438+.